Yahoo Finance Princeton Bancorp Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag
Princeton Bancorp (NASDAQ:BPRN) Full Year 2023 Results
Key Financial Results
Revenue: US$69.3m (down 4.4% from FY 2022).
Net income: US$25.8m (down 2.8% from FY 2022).
Profit margin: 37% (in line with FY 2022).
EPS: US$4.10 (down from US$4.19 in FY 2022).
BPRN Banking Performance Indicators
Net interest margin (NIM): 3.99% (down from 4.47% in FY 2022).
Non-performing loans: 0.43% (up from 0.02% in FY 2022).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Princeton Bancorp EPS Beats Expectations, Revenues Fall Short
Revenue missed analyst estimates by 1.3%. Earnings per share (EPS) exceeded analyst estimates by 1.3%.
In the last 12 months, the only revenue segment was Community Banking Operations contributing US$69.3m. The largest operating expense was General & Administrative costs, amounting to US$38.2m (88% of total expenses). Explore how BPRN's revenue and expenses shape its earnings.
Looking ahead, revenue is forecast to grow 1.9% p.a. on average during the next 2 years, compared to a 5.8% growth forecast for the Banks industry in the US.
Performance of the American Banks industry.
The company's share price is broadly unchanged from a week ago.
Risk Analysis
Before you take the next step you should know about the 2 warning signs for Princeton Bancorp (1 is a bit unpleasant!) that we have uncovered.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
